Biodexa Pharmaceuticals Plc ADR (BDRX) concluded trading on Wednesday at a closing price of $1.35, with 9.32 million shares of worth about $12.58 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -78.57% during that period and on Wednesday February 7 the price saw a loss of about -11.77%.
However, the stock later moved at a day high price of 2.0000, or with a loss of -11.77%. Stock saw a price change of -16.15% in past 5 days and over the past one month there was a price change of -42.06%. Year-to-date (YTD), BDRX shares are showing a performance of -49.63% which decreased to -99.48% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.23 but also hit the highest price of $261.76 during that period. The average intraday trading volume for Biodexa Pharmaceuticals Plc ADR shares is 673.03K. The stock is currently trading -25.72% below its 20-day simple moving average (SMA20), while that difference is down -47.00% for SMA50 and it goes to -77.63% lower than SMA200.
The stock has a current market capitalization of $0.32M and its 3Y-monthly beta is at 1.49. It has posted earnings per share of -$453.45 in the same period. It has Quick Ratio of 3.18 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BDRX, volatility over the week remained 29.53% while standing at 15.07% over the month.
Analysts are in expectations that Biodexa Pharmaceuticals Plc ADR (BDRX) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same.
